Northern Trust Discloses Dodd-Frank Act Stress Test Results

CHICAGO--(BUSINESS WIRE)-- Northern Trust Corporation (Nasdaq: NTRS) today disclosed the results of its company-run stress test under the severely adverse scenario developed by the Corporation for its Mid-Cycle 2019 submission. Northern Trust, as with other companies covered by the provisions of Section 165 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, is required to conduct company-run stress tests semi-annually and to disclose summary results of its company-run stress test under the severely adverse scenario. Northern Trust’s results may be found at:

https://cdn.northerntrust.com/pws/nt/documents/earnings/disclosures/mid-cycle-DFAST-results-disclosure.pdf

About Northern Trust

Northern Trust Corporation (Nasdaq: NTRS) is a leading provider of wealth management, asset servicing, asset management and banking to corporations, institutions, affluent families and individuals. Founded in Chicago in 1889, Northern Trust has offices in the United States in 21 states and Washington, D.C., and 23 locations in Canada, Europe, the Middle East and the Asia-Pacific region. As of September 30, 2019, Northern Trust had assets under custody of US$8.8 trillion, and assets under management of US$1.2 trillion. For more than 125 years, Northern Trust has earned distinction as an industry leader for exceptional service, financial expertise, integrity and innovation. Visit northerntrust.com or follow us on Twitter @NorthernTrust.

Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S. Global legal and regulatory information can be found at https://www.northerntrust.com/disclosures.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191031005927/en/

Media Contact:
Doug Holt
Northern Trust
(312) 557-1571
[email protected]
http://www.northerntrust.com

Source: Northern Trust Corporation

You May Also Be Interested In

• Northern Trust Expands Relationship with First Sentier Group to Support Singapore Unit Trust Offering
• HALF-YEAR FINANCIAL REPORT OF MARIMEKKO, 1 Jan–30 June 2026: Marimekko's Q2 net sales nearly at previous year's record level, driven by strong growth in APAC; operating profit behind comparison peri
• Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability